- Home
- Companies
- micronesia
- patient blood
Show results for
Refine by
Patient Blood Suppliers Serving Micronesia
102 companies found
based inFarmingdale, NEW YORK (USA)
We aim to have our proprietary procedural solutions become the standard of care and enhance patient outcomes throughout the world. We are doing that by building off our best in class surgical ultrasonic technology to change patient outcomes in ...
The Only Company that brings you a complete portfolio for your orthoplastic ...
based inTarpon Springs, FLORIDA (USA)
CytoVive specializes in regenerative and functional medicine, committed to advancing next-generation solutions for healthcare professionals, veterinarians, and scientific researchers. The company's offerings include medical devices, allograft ...
based inLoveland, COLORADO (USA)
Through innovation, invention, and strategic partnerships with worldwide leaders in diagnostics and treatments, Heska provides the benefits of latest generation technologies to pet healthcare providers. Heska’s range of complete blood diagnostic ...
based inDallas, TEXAS (USA)
Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C and GT production and ...
based inSt. Louis, MISSOURI (USA)
C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...
The PrecivityAD2™ blood test is intended for patients aged 55 and older with signs or symptoms of mild cognitive impairment or dementia, who are undergoing evaluation for Alzheimer’s disease or other ...
based inSanta Clara, CALIFORNIA (USA)
Proxim has developed a next-generation handheld immunodiagnostic device. The system performs the most important laboratory tests near the patient using whole blood without any sacrifice in sensitivity and precision, bringing the most critical ...
Proxim has developed a next-generation handheld immunodiagnostic device. The system performs the most important laboratory tests near the patient using whole blood without any sacrifice in sensitivity and precision, ...
based inMill Creek, WASHINGTON (USA)
Vmed veterinary monitors include the PC-VetGard+ wireless multi-parameter surgical monitor; PC-VetChek wireless ECG and recovery monitor for post surgical and critical care monitoring, ECG Lead II evaluation in pre-surgical screening or as part of ...
Oscillometric Blood Pressure System; Built-in, lighted display. Optional Bluetooth wireless computer link. Manual and automatic ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta and Carina Biotech to develop next-generation i-body enabled CAR-T cancer therapeutics. AdAlta has entered a collaboration agreement with Carina Biotech to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T ...
based inMonmouth Junction, NEW JERSEY (USA)
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world, as an extracorporeal ...
he CytoSorb therapy* is based on an extracorporeal blood purification procedure that was shown to effectively reduce excessive levels of inflammatory mediators (see “The Adsorber”). This is intended to alleviate the excess systemic ...
based inGirton, UNITED KINGDOM
Medovate works collaboratively with medical professionals to manufacture and bring to market valuable new medical technologies to facilitate enhanced patient care in both human and animal health. The Medovate team comprises experts in their ...
Helping to prevent incidences of inappropriate administration of insulin during blood ...
based inMountain View, CALIFORNIA (USA)
At Athelas, we're bringing simple, life-changing health care products to people around the globe. The future of healthcare is at the home - we are a team of technologists building the next generation of medical products at the intersection of ...
The Athelas Blood Pressure Cuff allows patients to automatically track and transmit their blood pressure readings to their physician from the comfort of home. Our blood pressure ...
based inHarrow, UNITED KINGDOM
Estar Medical is committed to the innovation and development of medical devices used for autologous regenerative biologics and to the creation of autologous therapies for the purpose of improving the patient’s quality of life. Estar Medical was ...
The system includes the following components: red stoppers, specially treated glass and a unique gel barrier. Tropocells® TRS is prepared by taking either 12ml or 23ml whole blood from the patient, then ...
based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
Genomic profiling of tissue samples provides a single point in space and time which is lacking the ability to reveal tumor heterogeneity and to test repeatedly to monitor the treatment efficacy. The risk of tissue biopsy is much higher for elderly ...
based inVaud, SWITZERLAND
Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices, intended for cells therapies. Regen Lab is a leading innovator of medical device in the field of ...
based inBizCentre, SINGAPORE
Incorporated in 2009, Biolidics Limited (“Biolidics” or the “Company” and together with its subsidiaries the “Group”) focuses on developing a portfolio of innovative diagnostic solutions to lower healthcare costs and improve clinical outcomes. To ...
Our ClearCell FX1 System is a fully automated device for cell retrieval that can separate and enrich wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood. It is driven by our CTChip®FR1 biochip, which is a ...
based inBoston, MASSACHUSETTS (USA)
We develop innovative medical technology products and services that improve the quality, effectiveness and efficiency of care. At Haemonetics, our Purpose inspires the important work we do every day to meaningfully advance patient care and drive ...
The Cell Saver Elite+ system provides hospitals with an easy-to-use, reliable way to recover and deliver back a patient’s own high-quality blood during medium to high blood loss ...
based inSpånga, SWEDEN
Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized hospitals, clinics, and laboratories in both human and veterinary ...
based inLakewood, COLORADO (USA)
Terumo Blood and Cell Technologies is a global leader in blood component, therapeutic apheresis and cellular technologies serving customers in more than 130 countries. As the only company with the unique combination of apheresis collections, manual ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for ...
